Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 2,015 |
|
|||||
| News | (1) | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Schrodinger Inc | SDGR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.22 | -1.04% | 21.00 | 08:49:24 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 21.22 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 31 | 2,015 | - | 20.56 - 59.24 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:46:54 | 25 | $ 20.99 | USD |
Schrodinger (SDGR) Options Flow Summary
Schrodinger Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.53B | 72.31M | - | 216.67M | 40.72M | 0.56 | 37.68 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Schrodinger News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SDGR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 22.93 | 22.93 | 20.56 | 21.37 | 671,988 | -1.93 | -8.42% |
| 1 Month | 22.97 | 23.47 | 20.56 | 21.98 | 627,561 | -1.97 | -8.58% |
| 3 Months | 27.43 | 29.15 | 20.56 | 23.99 | 706,654 | -6.43 | -23.44% |
| 6 Months | 32.49 | 38.00 | 20.56 | 27.08 | 820,787 | -11.49 | -35.36% |
| 1 Year | 40.738 | 59.24 | 20.56 | 33.60 | 957,222 | -19.74 | -48.45% |
| 3 Years | 77.51 | 79.75 | 15.85 | 34.37 | 780,080 | -56.51 | -72.91% |
| 5 Years | 30.45 | 117.00 | 15.85 | 46.49 | 897,156 | -9.45 | -31.03% |
Schrodinger Description
| Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. Schrodinger generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations. |
